Results
1 -
10 of
131 Alireza Azhdari Tehrani, Bahareh Mir Mohammad Sadegh and Hamid Reza Khavasi .
catena-Poly[[bis(pyrazine-2-carboxamide)mercury(II)]-di-[mu]-chlorido] , Acta Cryst (2010). E66, m261Â Â Anca-Iulia StoicaOn leave from the Department of Analytical Chemistry, Faculty of Chemistry, University of Bucharest., Clara Viñas and Francesc Teixidor.
Application of the cobaltabisdicarbollide anion to the development of ion selective PVC membraneelectrodes for tuberculosis drug analysis, Chem. Commun., 2008, 6492. Silvia Pacigová, Róbert Gyepes, Jozef Tatiersky and Michal Sivák.
Interpretation of the multiple vanadium-oxygen bonds in the central VO(η-O)group. Synthesis, structure, supramolecular interactions and DFT studies for complexes with 2,2′-bipyridine, 1,10-phenanthroline, pyrazinato(1−) and pyrazinamide ligands, Dalton Trans., 2008, 121. Meenakshi Anurag and Debasis Dash.
Unraveling the potential of intrinsically disordered proteins as drug targets: application to Mycobacterium tuberculosis, Mol. Biosyst., 2009, 5, 1752. Pawel Grobelny, Arijit Mukherjee and Gautam R. Desiraju.
Drug-drug co-crystals: Temperature-dependent proton mobility in the molecular complex of isoniazid with 4-aminosalicylic acid, CrystEngComm, 2011, 13, 4358. Heba Abourahma, Devon S. Cocuzza, Jesus Melendez and Jennifer M. Urban.
Pyrazinamide cocrystals and the search for polymorphs, CrystEngComm, 2011, 13, 6442. Stephen Michael Rajesh, Subbu Perumal, J. Carlos Menéndez, Perumal Yogeeswari and Dharmarajan Sriram.
Antimycobacterial activity of spirooxindolo-pyrrolidine, pyrrolizine and pyrrolothiazole hybrids obtained by a three-component regio- and stereoselective 1,3-dipolar cycloaddition, Med. Chem. Commun., 2011, 2, 626. Nabanita Saikia, Anupam N. Jha and Ramesh C. Deka.
Interaction of pyrazinamide drug functionalized carbon and boron nitride nanotubes with pncA protein: a molecular dynamics and density functional approach, RSC Advances, 2013, 3, 15102.